Alison A. Haggerty

Partner

New York
alison.haggerty@lw.com
+1.212.906.1320

PRACTICES

  • Capital Markets
  • Public Company Representation

INDUSTRIES

  • Healthcare & Life Sciences
  • Technology

BAR QUALIFICATIONS

  • New York

EDUCATION

  • JD, New York University School of Law, 2010
    cum laude
  • BS, University of North Carolina, Chapel Hill, 2004

PROFILE

Alison Haggerty advises issuers and investment banking firms in capital markets transactions, with a focus on initial public offerings, follow-on equity offerings, and convertible debt offerings in growth industries.

Alison serves a mix of companies and financial institutions in connection with complex equity and debt securities offerings. She brings particular experience handling capital markets transactions on behalf of all of the major US investment banks and leading innovators in technology, healthcare and life sciences, and retail and consumer products.

Alison also regularly counsels publicly traded companies on general corporate and securities law matters, including governance issues, reporting obligations, and stock exchange rules and requirements.

EXPERIENCE

Alison’s representative experience includes advising the issuer or underwriters in connection with securities offerings for the following companies:

  • ADC Therapeutics*
  • Aquantia
  • Axovant
  • Cara Therapeutics
  • Catabasis*
  • Datadog
  • Duolingo
  • Etsy
  • European Wax Center
  • Everyday Health
  • FIGS
  • Fluence Energy
  • Imara*
  • Immunovant*
  • MongoDB
  • Monte Rosa
  • Myovant Sciences
  • ODDITY Tech
  • Ovid
  • Prevail Therapeutics
  • Progyny
  • RenalytixAI*
  • Rivian
  • Roivant
  • Schrodinger*
  • Strongbridge Biopharma*
  • WAVE Life Sciences*
  • Zentalis Pharmaceuticals*

*Client represented prior to joining Latham